Search Tag: Xenios

ICU Management

Neonatal-and-pediatric-ecmo-with-minilung-petite-kit

2022 02 Nov

Fresenius Medical Care heart & lung launches patient kit, especially for neonatal and pediatric ECMO use Fresenius Medical Care’s heart & lung division Xenios AG introduced the MiniLung petite kit at ESICM LIVES congress this October. This patient kit was developed especially for neonatal and pediatric ECMO.    Fresenius Medical Care’s heart...Read more

ICU Management

Xenios-ag-receives-approval-in-china-for-ecmo-devices

2021 13 Jul

Xenios A6, a Fresenius Medical Care company, has received approval from the National Medical Products Administration (NMPA) in China for the Xenios console and patient kits for ECMO therapy. In early May, Xenios AG, a Fresenius Medical Care company, received approval for two patient kits in China. It follows NMPA's approval of the Xenios console...Read more

ICU Management

Xenios-ag-announces-changes-in-the-management-board

2021 31 Mar

The Management Board of Xenios AG , the Heart & Lung Business Unit of Fresenius Medical Care, has been restructured. Effective January 31, 2021, the previous Chair of the Executive Board, Dr. Andreas Terpin, has left the company. The new senior trio on the Management Board will continue Fresenius Medical Care's success in the field of extracorporeal...Read more

ICU Management

Novalung-system-receives-us-fda-clearance

2020 26 Feb

The US FDA (Food and Drug Administration) has granted 510(k) approval to Fresenius Medical Care North America and Xenios, a Fresenius Medical Care company, for long-term use of its Novalung system for patients with acute lung failure or acute cardiopulmonary failure. The FDA announced this on Friday evening. With class II approval, the Novalung...Read more

ICU Management

Merger-novalung-becomes-fully-integrated-within-xenios

2019 02 Sep

Novalung GmbH, which specialises in solutions for respiratory failure, was absorbed into Xenios AG on 30 August 2019. Processes will be streamlined as a result and the company will become more closely aligned with the parent company Fresenius Medical Care. Novalung was established in 2003 and specialises in the treatment of respiratory failure....Read more

ICU Management

Synchronised-cardiovascular-support-now-ready-for-the-market

2019 10 Jul

Xenios AG concludes its first clinical study on i-cor Synchronized Cardiac Assist, documenting the safety and feasibility of the synchronized cardiovascular support system. During the “SynCor” trial, a multicentre study treated 47 patients in nine different German clinics using an innovative pulsatile, cardiac-synchronous circulatory support...Read more

ICU Management

Relaunch-of-the-xenios-website-now-harmonised-with-that-of-its-parent-fresenius-medical-care

2019 08 May

The Xenios AG, pioneer in extracorporeal heart and lung support, has restructured its website. Xenios AG has been part of the Fresenius Medical Care Group since 2016 and the new design also serves to bring the company visually in line with the brand image of its parent.   www.xenios-ag.com   With this newly structured website, the...Read more